Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nucifora

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain familyS Fears, C Mathieu, N Zeleznik-Le, et al.
Leukemia|September 1, 1994
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21)G Nucifora, J I Dickstein, V Torbenson, et al.
Blood|October 9, 1998
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapyD Roulston, R Espinosa, G Nucifora, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomasB W Baron, G Nucifora, N McCabe, et al.
Radiology|March 30, 2016
Combat-related Mild Traumatic Brain Injury: Association between Baseline Diffusion-Tensor Imaging Findings and Long-term OutcomesJeffrey B Ware, Rosette C Biester, Elizabeth Whipple, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoterS Fears, M Gavin, D E Zhang, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic propertiesC Zent, N Kim, S Hiebert, et al.
Blood|February 15, 1993
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemiaG Nucifora, D J Birn, P Erickson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 1996
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter propertiesC S Zent, C Mathieu, D F Claxton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA bindingE N Hatada, A Nieters, F G Wulczyn, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain familyS Fears, C Mathieu, N Zeleznik-Le, et al.
Leukemia|September 1, 1994
Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21)G Nucifora, J I Dickstein, V Torbenson, et al.
Blood|October 9, 1998
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapyD Roulston, R Espinosa, G Nucifora, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomasB W Baron, G Nucifora, N McCabe, et al.
Radiology|March 30, 2016
Combat-related Mild Traumatic Brain Injury: Association between Baseline Diffusion-Tensor Imaging Findings and Long-term OutcomesJeffrey B Ware, Rosette C Biester, Elizabeth Whipple, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoterS Fears, M Gavin, D E Zhang, et al.
Current Topics in Microbiology and Immunology|January 1, 1996
Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic propertiesC Zent, N Kim, S Hiebert, et al.
Blood|February 15, 1993
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemiaG Nucifora, D J Birn, P Erickson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 1996
The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter propertiesC S Zent, C Mathieu, D F Claxton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1992
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA bindingE N Hatada, A Nieters, F G Wulczyn, et al.
Pageof 7